Koers Lexagene Holdings Inc Toronto S.E.
Aandelen
WEY
CA52886L1031
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01-03-18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24-03-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-18 |
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Tom Slezak
BRD | Director/Board Member | - | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-44,08% | 7,63 mld. | |
+8,98% | 3,61 mld. | |
+3,94% | 2,36 mld. | |
-24,94% | 1,86 mld. | |
-17,38% | 1,74 mld. | |
+4,89% | 913 mln. | |
+21,75% | 763 mln. | |
-11,57% | 678 mln. | |
-30,82% | 500 mln. |